TY - JOUR
T1 - Individualisation of radiation therapy for older persons with secondary brain lesions from carcinoma of the breast
AU - Rades, Dirk
AU - Nguyen, Trang
AU - Janssen, Stefan
AU - Khoa, Mai Trong
AU - Schild, Steven E.
N1 - Publisher Copyright:
© 2020 International Institute of Anticancer Research. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/4
Y1 - 2020/4
N2 - Background/Aim: Outcomes of older persons with secondary brain lesions from carcinoma of the breast may be improved by individualized therapy. This process will likely be easier with survival scores. Patients and Methods: A retrospective study was performed in 111 older patients with carcinoma of the breast irradiated for secondary brain lesions. Dose-fractionation, age, general condition, number of brain lesions, other visceral metastases and time period from breast cancer detection until radiation therapy were investigated. Results: Postradiation survival was significantly related to general condition (p<0.0001) and other visceral metastases (p=0.041). When using these characteristics, sum-scores of 0 (n=46), 1 (n=50) or 2 (n=15) points were gained. Sixand 12-month survival was 7% and 3% for 0 points, 43% and 19% for 1 point, and 73% and 52% for 2 points (p<0.0001). Conclusion: This survival score contributes to treatment individualisation of older patients with secondary brain lesions from carcinoma of the breast.
AB - Background/Aim: Outcomes of older persons with secondary brain lesions from carcinoma of the breast may be improved by individualized therapy. This process will likely be easier with survival scores. Patients and Methods: A retrospective study was performed in 111 older patients with carcinoma of the breast irradiated for secondary brain lesions. Dose-fractionation, age, general condition, number of brain lesions, other visceral metastases and time period from breast cancer detection until radiation therapy were investigated. Results: Postradiation survival was significantly related to general condition (p<0.0001) and other visceral metastases (p=0.041). When using these characteristics, sum-scores of 0 (n=46), 1 (n=50) or 2 (n=15) points were gained. Sixand 12-month survival was 7% and 3% for 0 points, 43% and 19% for 1 point, and 73% and 52% for 2 points (p<0.0001). Conclusion: This survival score contributes to treatment individualisation of older patients with secondary brain lesions from carcinoma of the breast.
UR - http://www.scopus.com/inward/record.url?scp=85082792589&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/692dc4fc-ec70-3cfd-a606-a14ec4a945ec/
U2 - 10.21873/anticanres.14191
DO - 10.21873/anticanres.14191
M3 - Journal articles
C2 - 32234925
AN - SCOPUS:85082792589
SN - 0250-7005
VL - 40
SP - 2271
EP - 2274
JO - Anticancer Research
JF - Anticancer Research
IS - 4
ER -